New specialised treatments for NHS patients

NHS England has announced the results of the first of two prioritisation rounds to decide which new specialised commissioning treatments and services will be made available for patients for the 2018/19 financial year.

Three new treatments and services were approved for funding including a treatment for HIV, a new specialised service for adults with primary ciliary dyskinesia, and a new specialised service for Stevens-Johnson syndrome.

Funding for the new treatments and services will begin from April and will benefit an estimated 300 patients in the first year and thousands more annually after that.

All the new treatments were assessed for their clinical benefit and cost by the Clinical Priorities Advisory Group (CPAG) made up of doctors, health experts and patient representatives.

The prioritisation process for new investment decisions has now moved from an annual cycle to twice a year in order to speed up the introduction of new treatments and services for patients.

Treatments are grouped into five levels of priority, with those that cost less and offer more clinical benefit for patients classified as level one, and treatments with the lowest clinical benefit and highest cost placed in level five.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho